---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-027259"
form_type: "8-K"
ticker: "IDYA"
cik: "0001676725"
company_name: "IDEAYA Biosciences, Inc."
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T03:59:19.446324+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# IDEAYA Biosciences increases director stock option grants; votes at annual meeting

## Summary
- Initial director stock option grant increased from 22,000 to 32,400 shares.
- Annual director stock option grant increased from 11,000 to 16,200 shares.
- Three Class I directors elected: Yujiro Hata (41.3M for), Garrett Hampton (36.4M), Catherine Mackey (41.0M).
- Ratification of PricewaterhouseCoopers as auditor for 2023 with 44.6M for, 49,514 against.
- Board approved compensation changes on June 6, 2023, based on peer group data.

## SEC filing metadata
- accession: 0000950170-23-027259
- form_type: 8-K
- ticker: IDYA
- cik: 0001676725
- company_name: IDEAYA Biosciences, Inc.
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676725/000095017023027259/0000950170-23-027259-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676725/000095017023027259/idya-20230606.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-027259
- JSON: https://secwatch.observer/filing/0000950170-23-027259.json
- Plain text: https://secwatch.observer/filing/0000950170-23-027259.txt

## Key facts
- Shareholder Votes
  IDEAYA Biosciences, Inc. shareholders approved Ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2023 at the 2023-06-07 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-07
  source text: Proposal 2 . The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2023: Votes For Votes Against Abstentions 44,628,878 49,514 999
  evidence_url: https://www.sec.gov/Archives/edgar/data/1676725/000095017023027259/0000950170-23-027259-index.htm
- Shareholder Votes
  IDEAYA Biosciences, Inc. shareholders approved Election of three Class I directors to hold office until the 2026 annual meeting of stockholders or until their respective successors are elected at the 2023-06-07 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-07
  source text: Proposal 1. The election of three Class I directors to hold office until the 2026 annual meeting of stockholders or until their respective successors are elected: Nominee Votes For Votes Withheld Broker Non-Votes Yujiro S. Hata 41,311,283 1,117,424 2,250,384 M. Garret Hampton, Ph.D. 36,443,001 5,985,706 2,250,384 Catherine J. Mackey, Ph.D. 40,989,747 1,438,960 2,250,384
  evidence_url: https://www.sec.gov/Archives/edgar/data/1676725/000095017023027259/0000950170-23-027259-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.